×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Addex Therapeutics Ltd (ADXN) Q4 2023 Earnings Call Transcript
Seeking Alpha
Addex Therapeutics Ltd (NASDAQ:NASDAQ:ADXN) Q4 2023 Earnings Conference Call April 18, 2024 10:00 AM ETCompany ParticipantsTim Dyer - Chief...
1 month ago
Addex spinoff Neurosterix debuts with $63m for developing neurological therapies
Pharmaceutical Technology
Addex has also sold its preclinical neurological assets and drug discovery platform to Neurosterix for $5.5m and 20% equity.
2 months ago
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
markets.businessinsider.com
Shares of Biophytis S.A. (NASDAQ:BPTS) rose sharply in today's pre-market trading after reporting FY23 results. Biophytis posted a FY23 l...
1 month ago
Addex stock plunges 50% on failed study for epilepsy drug (NASDAQ:ADXN)
Seeking Alpha
Addex Therapeutics (ADXN) stock plunged 50% Monday on news that a Phase 2 epilepsy study for its drug ADX71149 had failed to meet its...
1 month ago
Charcot-Marie-Tooth Disease Market Size and Share to Grow by 2032, Predicts DelveInsight | Key Players in the ...
GlobeNewswire
The increase in the Charcot-Marie-Tooth disease market size is a direct consequence of increasing prevalent population of...
8 months ago
Addex further improves liquidity
European Biotechnology
Following a private placement worth CHF3m in February, Swiss allosteric modulator specialist Addex Therapeutics has increased its capital to...
84 months ago
The delisting dilemma: Why do so many biotechs face being kicked off the Nasdaq?
Fierce Biotech
The latest fear stalking biotech boadrooms is the postman delivering a letter from Nasdaq warning the company's stock faces being delisted.
14 months ago
Charcot Marie Tooth Disease Therapeutic Market Size Expected to Expand at a CAGR of +25% for the Study Period ...
openPR.com
Press release - Report Consultant - Charcot Marie Tooth Disease Therapeutic Market Size Expected to Expand at a CAGR of +25% for the Study...
28 months ago
Know Reasons Why Metabotropic Glutamate Receptor Market May See Potentially High Growth Factors
openPR.com
Advance Market Analytics released a new market study on Global Metabotropic Glutamate Receptor Market with 100+ market data Tables,...
52 months ago